NCT01906684 - Comprehensive Analysis of Relapse in Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2015

Conditions

Multiple Sclerosis

Interventions

DRUG

Acthar Gel

Patients who present with MS relapse within 72 hours of onset will be recruited for study. Upon consent they will be administered Achtar Gel for 5-14 days as clinically appropriate.

Trial Locations (1)

35209

Tanner Center for MS, Birmingham